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THE REACTION of diisopropylfluorophosphate (DFP) with the amino acid 
group that forms the reactive center for several enzymes is shown in figure 1. 
The DFP molecule forms an irreversible bond with these enzymes, releasing HF 
and yielding a diisopropylphosphate-enzyme molecule. When the enzyme is 
broken down, diisopropylphosphat e (DIP) is released. DIP is nonreactive and 
is promptly excreted. 
The irreversibility of the bond and the lack of reutilization of the breakdown 
product suggested the use of this molecule, when tagged with P 32 , as a celllabel.2 
We have been concerned with the use of DFP32 as a granulocyte label. This can 
be done if certain criteria are met. First, since the enzymes that are bound by 
DFP are present in red cells, plasma, and platelets, isolation of the leukocytes 
must be complete. Second, of the leukocytes in the blood, only granulocytes 
must label to a significant degree. Finally, there should be no measurable effect 
of the DFP on granulocyte function in the concentration used to label the cells. 
The evidence that these criteria have been fulfilled has been presented.1 
Granulocytes have been labeled both in vivo and in vitro by DFP32 • In vivo 
labeling has been done by the intravenous injection of DFP32 • Granulocytes are 
labeled in vitro by drawing whole blood into plastic bags with ACD solution as 
an anticoagulant and incubating the blood for one hour with DFP32 • The labeled 
blood is then returned to the subj ect. The methods for isolation of the leukocytes 
and determination of their radioactivity have been described.1 
A representative leukocyte radioactivity curve obtained after the intravenous 
inj ection of DFP32 is shown in figure 2. The lower curve represents the radio-
activity as CPM per mg. of leukocyte nitrogen. The upper curve is drawn through 
the logarithms of the leukocyte radioactivities. 
During the first two days after the inj ection of the DFP2 , there is a rapid 
decrease in leukocyte radioactivity (phase I ). The leukocyte radioactivity then 
remains fairly constant until the 11th day (phase II). A final decrease in radio-
activity (phase III) follows. By about the 24th day, no radioactivity can be 
measured in the leukocyte samples. 
The results obtained in two subj ects after in vitro labeling of their granulocytes 
are shown in the lower portion of figure 3. The leukocyte radioactivities are 
expressed as the logarithms of the CPM per mg. of nitrogen. For comparison, in 
the upper portion of this figure the logarithms of the leukocyte radioactivities 
obtained during phase I, after in vivo labeling of leukocytes in two subj ects, are 
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Fw. 1.- Model of the reaction of DFP with the active serine group of an enzyme . Gly, 
Asp, and Glu refer to the amino acids glycine, aspartic acid, and glutamic acid (from Athens 
et al.: Blood 14: 303, 1959) . 
shown. The open circles are the logarithms of the values obtained by subtracting 
the mean phase II values from phase I. 
If the curve obtained after in vitro labeling is compared with the curve ob-
tained after in vivo labeling, a clear difference can be seen. Analysis of the curves 
makes it appear likely that granulocytes in sites other than the blood are being 
labeled by the in vivo method. 
To assist in the analysis of the curves, kinetic models were set up on an analog 
computor and tested for feasibility. The first step was to define the possible types 
of cell compartments that might be present in any granulocyte kinetic model. 
These types are represented in figure 4. In this figure, the cells entering the 
compartments are considered to be unlabeled, whereas those in the cell com-
partments are considered to be labeled maximally at zero time. 
A type I compartment is a simple, miscible pool of cells that leave in a random 
fashion. The radioactivity expected in the cells coming from this pool after time 
to would reflect the average radioactivity of the pool itself and would decrease 
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FIG. 2.-Arithmetic and semilogarithmic curves of t he leukocyte radioactivities obtained 
afte r t he intravenous inj ection of DFP32 • Each curve represents t he mean of seven indi -




T ABLE I. - Comparison of the I n Vivo Phase I with the 
Disappearance of I n Vitro Labeled Cells 
No. Subjects M ean TJ-2 ± S.E. (H ours) 
30 6.4 ± 0. 37 
20 7.4 ± 0 .33 
p 
>0.05 
in an exponential manner_ The mathematical expression of this decrease is given 
below the model. 
A type II compartment would be expected if cells in a particular phase must 
spend a definite time in the phase before release. Thus, the cells would behave as 
if they were coming down a tube, aging as they proceed, pushing before them 
older cells and being replaced by younger cells. Once the cells in the tube had 
been labeled, there \\-ould be no change in the radioactivity of cells leaving the 
tube, until the youngest cells at the time of labeling had left and were replaced 
by cells that were not in the tube at the time of labeling. At this time, the radio-
activity of the cells leaving the tube would suddenly fall to zero. The mathe-
matical expression of the radioactivity of the cells leaving the tube is given 
below this model. Time t1 is the time when the last labeled cells leave the tube_ 
From to to t1 is the transit time through the tube_ A sample of blood drawn for 
analysis at any time would reflect the average concentration of label in the pool 
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FrG. 3.-Comparison of the in vivo phase I curves (top) with the disappearance of in vi tor 
labeled granulocytes. 
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FIG. 4.-Types of cell compartments that may be present in a granulocyte kinetic model 
The type III compartment is similar to the type II compartment, except t hat 
there is some degree of random distribution of the transit time through the tube. 
Thus, after the cells in the tube had been labeled, no change in the radioactivity 
of the cells leaving the tube would be expected until time t1 , the minimum transit 
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time. The rate of decrease would become maximal at time t2 , when most of the 
labeled cells were being replaced by unlabeled cells. Some radioactivity would 
remain in the cells coming out after this time because of mixing of lagging labeled 
cells with the unlabeled cells. The mathematical expression of the radioactivity 
of cells coming from this pool is given below the model. R is the maximal rate of 
change of radioactivity in the emerging cells and occurs at time t2 . 
From the radioactivity curves obtained after labeling granulocytes with DFP32 
in vitro, certain deductions concerning the removal of granulocytes from blood 
can be made. If granulocytes leave t he blood in a random fashion, the blood pool 
of granulocytes would represent a type I compartment. The fact that the time 
course of in vitro labeled cells falls exponentially argues for the validity of this 
concept (fig. 3). If, on the other hand, granulocytes leave the blood compartment 
in a sequence determined by their t ime of entry, then the blood compartment 
would be type II. Since this model would predict a linear decrease in labeled 
cells, it can be discarded as not compatible with our data. However, the possibility 
must also be considered that granulocytes are removed from the blood by a 
combination of these two methods of removal. To investigate this possibility, 
three such models have been analyzed with the analog computor, but will not 
be described here. Observations made from these models suggest to us that 
granulocytes are removed from the blood in a random fashion, entirely or pre-
dominantly, independently of the length of time that the cells have circulated in 
the blood. 
From the curves obtained after the in vitro labeling of granulocytes, informa-
tion concerning the return of granulocytes from the tissues to the blood can be 
obtained. The model that is shown in figure 5 was subjected to computor analysis. 
At a rate of return equal to one-half the rate of removal from the blood (k2 = 
7~ k1), the lower limits of the size of the tissue pool could be defined. F air approxi-
mation of the data and computor curves were obtained when TTT was allowed to 
be greater than 2.6 times the size of the blood pool (VB) . Upper limits for the return 
T 
2. 6 V B 10 VB VT = 100 VB 
FIG. 5.-Model for possible return of granu locytes from t issues. The method by which 
the limits can be set for t he size of VT for any k 2 is shown below. 
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of cells from tissues can be defined by analysis of the in vivo curves, as will be 
described. 
The curves obtained after the in vitro labeling of granulocytes are also of 
assistance in the analysis and interpretation of the more complex curves obtained 
following the in vivo labeling of granulocytes. As shown in figure 3 and table 1, 
the mean half-life of the phase I portion of the curves obtained after in vivo 
labeling and the half-time of disappearance of in vitro labeled cells are similar. 
This suggests that phase I of the in vivo curve is due to the removal of granulo-
cytes from the blood. This explanation could be valid if it were assumed that the 
cells in the blood at the time of the intravenous injection of DFP32 are labeled to 
a greater degree than the cells in the marrow and tissues. This assumption would 
seem to be resonable, since it would be expected that the circulating cells would 
be exposed to a higher initial concentration of DFP32 • Therefore, in the analysis 
of the in vivo curves in the analog computor we have assumed that phase I is 
explained by the removal of highly labeled cells from the blood compartment. 
On this assumption the initial relative radioactivity of blood granulocytes has 
been given a value of 100. The radioactivity of the cells in all other compartments 
has been set at 30. This value was selected because the granulocyte radioactivity 
levels during phase II are about 30 per cent of the initial value of phase I. Models 
composed of several postulated anatomic and kinetic granulocyte compart-
ments were then constructed and submitted to analysis in the analog computor. 
A composite model is shown in figure 6 . 
.Lvf1 is the pool of mitotically active cells in the marrow. The assumption has 
been made that the label in this pool decreases in an exponential manner because 
of cell division and that the level of radioactivity in the cells leaving this pool 
reflects the radioactivity of the pool. Therefore, this is considered a type I 
compartment. Cells leaving the mitotic pool (.Ll11 ) enter a maturation phase 
(M2), from which they normally would not be released until maturation had been 
completed. 1\12 is thus a type II compartment. lVI 3 represents a storage pool of 
mature granulocytes in the bone marrow which is ready for release into the 
blood. The cells contained in this pool, all being mature, are thought to be re-
leased in a random fashion, representing a type I compartment. B is the granulo-
cyte pool in the blood. The small "X" compartment in equilibrium with the 
blood acknowledges the nonhomogeneous nature of the blood pool. If equilibra-
FIG. 6.-A composite granulocyte kinetic model. 
1. VM, is equivalent to VM 3 in its effect on the shape of the curve. 
2. With M 1 and M 3 present, only the sum of VM 1 and VM 3 influence the curve. 
3. The upper limit of VM 1 and VM 3 is 10 VB if k2 = 0. 
4. The in vitro curve and phase I of the in vivo curve define the lower limit of V T for a 
given k 2 • 
5. The upper limit of VT is defined by phase III of the in vivo curve for a given k2 . 
6. As VT increases, VM 1 and VM 3 must decrease in size. 
.. . 
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time. The rate of decrease would become maximal at time t2 , when most of the 
labeled cells were being replaced by unlabeled cells. Some radioactivity would 
remain in the cells coming out after this time because of mixing of lagging labeled 
cells with the unlabeled cells. The mathematical expression of the radioactivity 
of cells coming from this pool is given below the model. R is the maximal rate of 
change of radioactivity in the emerging cells and occurs at time t2 . 
From the radioactivity curves obtained after labeling granulocytes with DFP32 
in vitro, certain deductions concerning the removal of granulocytes from blood 
can be made. If granulocytes leave t he blood in a random fashion, the blood pool 
of granulocytes would represent a type I compartment. The fact that the time 
course of in vitro labeled cells falls exponentially argues for the validity of this 
concept (fig. 3). If, on the other hand, granulocytes leave the blood compartment 
in a sequence determined by their t ime of entry, then the blood compartment 
would be type II. Since this model would predict a linear decrease in labeled 
cells, it can be discarded as not compatible with our data. However, the possibility 
must also be considered that granulocytes are removed from the blood by a 
combination of these two methods of removal. To investigate this possibility, 
three such models have been analyzed with the analog computor, but will not 
be described here. Observations made from these models suggest to us that 
granulocytes are removed from the blood in a random fashion, entirely or pre-
dominantly, independently of the length of time that the cells have circulated in 
the blood. 
From the curves obtained after the in vitro labeling of granulocytes, informa-
tion concerning the return of granulocytes from the tissues to the blood can be 
obtained. The model that is shown in figure 5 was subjected to computor analysis. 
At a rate of return equal to one-half the rate of removal from the blood (k2 = 
7~ k1), the lower limits of the size of the tissue pool could be defined. F air approxi-
mation of the data and computor curves were obtained when TTT was allowed to 
be greater than 2.6 times the size of the blood pool (VB) . Upper limits for the return 
T 
2. 6 V B 10 VB VT = 100 VB 
FIG. 5.-Model for possible return of granu locytes from t issues. The method by which 
the limits can be set for t he size of VT for any k 2 is shown below. 
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t ion were rapid between cells in the circulating blood and t he marginal population 
of granulocytes described by Vejlens,6 as well as with other possible intravascular 
pools in the spleen, lungs, etc., the main effect of this "X" pool would be t o lead 
to underestimation of the size of the population of blood granulocytes, since 
only blood volume and granulocyte concent ration are measured . F inally, T is 
the possible t issue pool of granulocytes that may be in equilibrium with blood 
granulocytes. 
By setting up variations of this basic model on the analog computor and 
comparing the results with the in vivo data curve, certain generalizations have 
been made concerning the nature of this granulocyte kinetic model. These 
generalizations are given in figure 6. Needless to say, the validity of the model 
depends upon the validity of the basic assumptions already stated . 
One of the most interesting observations drawn from this analysis is the limit 
that can be set on the amount of granulocyt e return from t issues to blood. Using 
analysis of the in vitro curve and the in vivo curve to set limits for the size of the 
t issue pool and the rate of return, as expressed in generalizations 4 and 5 of 
figure 6, a maximum return rate amount ing to 0.3 of the removal rate is found 
to be compatible with the data curves. 
If a type III compartment replaces the type II compartment that was used t o 
represent the marrow maturation phase in the previous model, a fit can be ob-
tained with the data curve, even if no labeling of the mitot ic pool is allowed and 
the marrow storage pool is disregarded. The standard deviation of random 
distribut ion about the mean transit time through the compartment had to be 
two days. This model is shown in figure 7. The bot tom curve represents the 
random distribut ion of transit time through the compar tment . The middle curve 
is obtained from the computor model, and upper curve is the data curve. 
So far it has not been possible to construct a more exact granulocyt e kinetic 
model from the DFP32 data than that presented in figure 6, because of lack of 
information concerning the degree and extent of marrow labeling. In the near 
future, it is planned to use trit ium-labeled DFP. D emonstrations of the exact 
distribution of DFP within the granulocyte series should be possible with 
radioautography of marrow and blood samples. With this information, elimina-
FIG. 7.-A type of granulocyte k inetic model (wit h type III compar tment) with random 
distribution in t he maturation phase. The computor model curve is compared with t he 
in vivo data curve. The standard deviation of r andom distribut ion was set at two days. 
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FIG. 8.-The simplest granulocyte kinetic model (model "T" ) by which the analog com-
putor curve can be made to approximate the in vivo data curve. 
1 _ d c),) = kJ cM1 
. dt VM) 
2. CM 2 (out) = CM 2 (initial) fort ( t 1 
3. CM 2 (out), = CM 2 (in) (t-t1 > 
d CB ka 4. - - - = - [CB - CM 2 (out)] dt VB 
tion of several of the present models should be possible, and a closer approxima-
tion of the actual granulocyte kinetic model may result. 
With granulocyte kinetic models, calculations of certain kinetic data can 
be made. To demonstrate the type of information that can be gained from 
analysis of the DFP32 curve by means of a kinetic model, the simplest workable 
model will be used as an example. This model, with its defining formulae, is 
shown in figure 8. The designation "T" is employed to suggest that, just as with 
the early Ford cars, when more information about the mechanism is obtained, 
more and better models will follow. 
In the analysis of the DFP32 in vivo data curve by this model, phase I repre-
sents the removal of blood granulocytes, and because no return of granulocytes 
from tissues is allowed, this is equal to granulocyte turnover. The granulocyte 
turnover, in turn, represents production in the steady state. Phase II is the time 
necessary for transit through the maturation tube. The shape of the curve in 
phase III is influenced in this model by the rate of granulocyte turnover through 
blood and the decrease in radioactivity because of cell division in the mitotic 
TABLE 2.- Results of Analysis of Model "T" 
Phase I 
T;-2 = 6.4 hours 
Granulocyte turnover time in blood = 9.4 hours 
Number of times the blood granulocyte population is turned over per day = 2.5 
Calculated number of blood granulocytes = 25 X 109 
Number of granulocytes turned over per day = 62.5 X 109 
% of blood granulocytes turned over per hour = 10% 
Phase II 
Duration = 11 days 
Time spent in maturation tube = 11 days 
Size of maturation tube = 27 .5 X blood granulocytes = 687 .5 X 109 
Phase III 
T% = 3 days 
Generation time of mitotic pool = 3 days 
Size of mitotic pool = 7.5 X blood granulocytes = 187 .5 X 109 
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TABLE 3.-Compa?·ison of Granulocyte Kinetic Estimates 
(Expressed as Cells X w-9/Kg . Body Wt.) 
Cells Produced Total Marrow 
Per Day Population 
Osgood . ... . .. .. . .. . . . ..... . . . 25.7 
Patt...... . ... . ....... . . . 2.6 8.3 
Donohue et a!.. ....... .. .... .. . . . .. ... . 11.4 







pool. Because of the rapidity of cell turnover through blood, the slope of the line 
is influenced primarily by the effect of cell division in the mitotic pool. Thus, 
assuming phase III to be a simple exponential decrease, by measuring the half-
time, one obtains a fair approximation in this model of the doubling time in the 
mitotic pool. 
With this model, the kinetic calculations presented in table 2 were obtained. 
Comparisons of these calculations with those of Osgood,4 Patt, 5 and Donohue 
et al.3 are shown in table 3. 
Obviously more work is required to define more exactly the granulocyte kinetic 
model and its relationship to the DFP32 data. However, as demonstrated by the 
analysis of the simple model presented above, one may expect to obtain valuable 
data concerning granulocyte kinetics in normal and pathologic conditions when 
these definitions have been established. 
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